EDX Medical Group plc has secured funding totalling up to £4 million.

A share placing will raise £2m while a new convertible loan note agreement for up to £2m will be issued to Professor Sir Chris Evans, the company’s founder and chief scientific officer.

EDX Medical develops digital diagnostic products and services supporting personalised treatments for cancer, cardiovascular and infectious diseases.